Egg Yolk Phospholipids.

Phosphatidylcholine is the main dietary form of choline and egg yolk is its richest common source, so this ingredient is a choline delivery vehicle rather than a separate nutrient. Free choline and the phospholipid feed the same body pool from opposite ends of the Kennedy pathway.

Betaine is formed by oxidation of choline and donates a methyl group to convert homocysteine back to methionine. Adequate betaine spares choline for phospholipid synthesis instead of methyl donation, so the two are linked in both directions.

The folate-dependent and choline-dependent routes to methionine are interchangeable, so low folate raises the draw on the choline pool and the same is true in the other direction. Phosphatidylcholine synthesis via PEMT is one of the largest consumers of methyl groups in the body.

Methionine synthase needs B12 as its cofactor to use the methyl group folate carries, so a shortfall pushes methylation demand onto the betaine and choline route. The three sit at one metabolic node.

DHA in yolk and in neural membranes is carried at the sn-2 position of phosphatidylcholine, and lysophosphatidylcholine-DHA is the form the Mfsd2a transporter takes across the blood-brain barrier. Delivering DHA on a phospholipid backbone matches the physiological carrier.

Krill oil delivers EPA and DHA bound to phospholipids rather than as triglycerides or ethyl esters, the same structural principle as yolk phospholipids. Both bypass the need for extensive lipolysis before micelle formation.

Phosphatidylserine is synthesised in mammalian tissue by base exchange from phosphatidylcholine or phosphatidylethanolamine, so the two are interconvertible members of one membrane pool. Formulas pair them because they occupy different leaflets of the same bilayer.

Alpha-glycerophosphocholine is a deacylation product of phosphatidylcholine and a direct precursor for both free choline and membrane phospholipid resynthesis. The two components enter the same pool at adjacent steps.

CDP-choline is the rate-limiting intermediate of the Kennedy pathway, the step immediately before phosphatidylcholine is assembled. Supplying the finished phospholipid and the intermediate feeds the same synthesis route at two points.

Lutein presented in an egg phospholipid matrix reaches the plasma far more readily than the crystalline form, because the phospholipid provides a ready-made emulsified carrier. This is a delivery effect on a lipophilic partner rather than a shared pathway.

The phytosome technology binds a poorly soluble polyphenol to phosphatidylcholine so it presents a lipophilic face to the enterocyte membrane, raising absorption several-fold. Yolk phospholipids are the same chemistry supplied as an ingredient.

Silybin is bound to phosphatidylcholine for the same reason as curcumin, because the free flavonolignan is barely absorbed on its own. The phospholipid acts as the carrier rather than as an active in this pairing.

Ubiquinol is a large, highly lipophilic quinone whose uptake depends on micelle formation with dietary lipid and emulsifiers. Phospholipids are the standard emulsifying carrier in soft-gel CoQ10 formulations.

Cholecalciferol is absorbed through mixed micelles and its uptake rises when taken with a lipid source. Phospholipids serve that role while also acting as emulsifiers in the formulation itself.

Bile salts are required to disperse dietary phospholipid into mixed micelles before phospholipase A2 acts on it. Where bile output is low, the emulsification step is the limiting one for any phospholipid ingredient.

Egg yolk phospholipids carry long chain polyunsaturated fatty acids at the sn-2 position, and those bonds are the ones peroxidation attacks first. Alpha tocopherol sits in the membrane and terminates the propagating chain. Tocopherol is added to phospholipid concentrates for exactly this reason, which is formulation chemistry rather than a clinical claim.

Phospholipids are amphiphilic and form mixed micelles with bile salts, which is the step that gets triglyceride-bound fatty acids across the unstirred water layer. Adding a phospholipid to a triglyceride oil increases the emulsified surface available to pancreatic lipase. The mechanism is settled; the size of any gain depends on the meal and the dose.

Astaxanthin is a lipophilic xanthophyll with poor uptake from a dry powder. A phospholipid matrix disperses it into micelles and keeps it in the lipid phase through digestion. Phospholipid dispersions are standard practice for carotenoid delivery.

Retinyl esters need micellar solubilisation before enterocyte uptake. Egg yolk phospholipids supply the emulsifier that forms those micelles, which is why they appear in fat-soluble vitamin premixes. This concerns delivery, not any additional activity of the vitamin.

Carotenoid uptake depends on the amount and type of lipid eaten in the same meal. A phospholipid emulsifier lowers the lipid threshold needed to form usable micelles. The effect is on how much reaches the blood, a marker, not on any downstream endpoint.

Menaquinone-7 is highly lipophilic and its uptake tracks the lipid content of the meal it is taken with. Phospholipid carriers are used in soft gel formats to hold it in a dispersible lipid phase. This is a delivery relationship.

Pancreatic lipase acts at the lipid and water interface, so its rate depends on emulsified surface area rather than on total fat alone. Phospholipids expand that interface. Where lipase output is low, the emulsifier and the enzyme address different halves of the same step.

A phospholipid disperses dietary fat into fine droplets, and the lipase and colipase in an enzyme blend then hydrolyse those droplets. The two steps are sequential, so a formula containing both covers emulsification and hydrolysis. This is digestive mechanics, not a claim about any condition.

Phosphatidylcholine is the largest single class within an egg yolk phospholipid concentrate, typically alongside phosphatidylethanolamine, sphingomyelin and lysophospholipids. Adding isolated phosphatidylcholine raises that one class without changing the rest. Anyone counting total choline should count both sources rather than one.

Both are phospholipid emulsifiers, but their fatty acid profiles differ: egg yolk phospholipids carry arachidonic acid and DHA at the sn-2 position while plant lecithin carries mainly linoleic acid. Formulas sometimes use both to hit an emulsification target while controlling cost. The functional overlap is on emulsification, not on fatty acid supply.

Medium chain triglycerides are hydrolysed rapidly and their fatty acids are absorbed without needing extensive micellar solubilisation. Pairing them with a phospholipid gives a formula both a fast-absorbing lipid and an emulsifier for the slower lipophilic actives. The two contribute different things to the same lipid phase.

Ubiquinone is a large lipophilic quinone with notoriously low uptake from crystalline powder. Phospholipid dispersion keeps it solubilised through gastric transit. This is the same logic behind commercial phospholipid CoQ10 systems and it concerns blood levels, a marker.

Krill oil delivers EPA and DHA already bound to phospholipids, and egg yolk phospholipids deliver arachidonic acid and DHA on the same backbone class. A formula carrying both raises total phospholipid-bound long chain fatty acid intake from two sources. Neither substitutes for the other on fatty acid profile.

Divalent calcium precipitates free long chain fatty acids as insoluble soaps in the intestinal lumen, and phospholipid hydrolysis releases exactly those fatty acids. High calcium doses taken in the same window reduce the fraction available for micellar uptake. Spacing the doses avoids the overlap.

Psyllium forms a viscous gel that slows diffusion of mixed micelles to the brush border and binds bile acids. Taken with a phospholipid-delivered lipophilic active, it lowers how much of that active is picked up in the same meal. Separating them by a couple of hours is the usual handling.

Activated charcoal adsorbs lipophilic molecules broadly, including fat-soluble vitamins and phospholipid-carried actives. Co-ingestion removes part of the dose from the lumen. Charcoal is dosed well away from any lipid-delivered nutrient.